CACNA1C (CaV1.2) and other L-type calcium channels in the pathophysiology and treatment of psychiatric disorders: advances from functional genomics and pharmacoepidemiology
A role for voltage-gated calcium channels (VGCCs) in psychiatric disorders has long been postulated as part of a broader involvement of intracellular calcium signalling. However, the data were inconclusive and hard to interpret. We review three areas of research that have markedly advanced the field...
Main Authors: | Harrison, PJ, Husain, SM, Lee, H, De Los Angeles, A, Colbourne, L, Mould, A, Hall, NAL, Haerty, W, Tunbridge, EM |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Elsevier
2022
|
Similar Items
-
Brain-enriched CACNA1C isoforms as novel, selective targets for psychiatric indications
by: Hall, N, et al.
Published: (2021) -
Long-read sequencing reveals the complex splicing profile of the psychiatric risk gene CACNA1C in human brain
by: Clark, MB, et al.
Published: (2019) -
The psychiatric and neural effects of L-type calcium channel antagonism: pharmacoepidemiology and experimental medicine studies
by: Colbourne, CL
Published: (2024) -
Voltage-gated calcium channel blockers for psychiatric disorders: genomic reappraisal
by: Harrison, PJ, et al.
Published: (2019) -
A rare schizophrenia risk variant of CACNA1I disrupts CaV3.3 channel activity
by: Andrade, A., et al.
Published: (2017)